Clinical trial
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to…
NCT00365898 · Purdue Pharma LP, Industry · Terminated
Key facts
| NCT number | NCT00365898 |
|---|---|
| Title | Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain |
| Official title | A Study of the Efficacy and Safety of 8 Mg Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Non-Malignant Pain |
| Intervention type | Drug |
| Interventions | Hydromorphone Hydrochloride Extended-Release |
| Enrollment | 380 |
| Start date | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Aug 18, 2006 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: